The personal genome project Canada: Findings from whole genome sequences of the inaugural 56 participants

CMAJ

Volumn 190, Issue 5, 2018, Pages E126-E136

  Reuter, Miriam S ^a   Walker, Susan ^a   Thiruvahindrapuram, Bhooma ^a   Whitney, Joe ^a   Cohn, Iris ^b   Sondheimer, Neal ^b,c   Yuen, Ryan K C ^a,d   Trost, Brett ^a   Paton, Tara A ^a   Pereira, Sergio L ^a   Herbrick, Jo Anne ^a   Wintle, Richard F ^a   Merico, Daniele ^a,e   Howe, Jennifer ^a   MacDonald, Jeffrey R ^a   Lu, Chao ^a   Nalpathamkalam, Thomas ^a   Sung, Wilson W L ^a   Wang, Zhuozhi ^a   Patel, Rohan V ^a   Pellecchia, Giovanna ^a   Wei, John ^a   Strug, Lisa J ^a   Bell, Sherilyn ^a   Kellam, Barbara ^a   Mahtani, Melanie M ^a   Bassett, Anne S ^e   Bombard, Yvonne ^f,g   Weksberg, Rosanna ^b,d   Shuman, Cheryl ^b,d   Cohn, Ronald D ^c,d   Stavropoulos, Dimitri J ^h   Bowdin, Sarah ^b,h   Hildebrandt, Matthew R ^b   Wei, Wei ^b   Romm, Asli ^b   Pasceri, Peter ^b   Ellis, James ^b,d   Ray, Peter ^h   Meyn, M Stephen ^b,d   Monfared, Nasim ^b,h   Hosseini, S Mohsen ^a,b   Joseph George, Ann M ^b   Keeley, Fred W ^c   Cook, Ryan A ^c   Fiume, Marc ^a,c   Lee, Hin C ^c   Marshall, Christian R ^a,h   Davies, Jill ^d   Hazell, Allison ^d   Buchanan, Janet A ^a   Szego, Michael J ^d,i   Scherer, Stephen W ^a,c   more..

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h Laboratory Medicine   (Canada)

ⁱ ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CANCER RISK; CHROMOSOME ABERRATION; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENETIC COUNSELING; GENETIC DATABASE; GENETIC VARIATION; GENOME ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOGENOMICS; PRACTICE GUIDELINE; WHOLE GENOME SEQUENCING; DNA SEQUENCE; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; PROCEDURES; RECESSIVE GENE;

CANADA; FEMALE; GENES, RECESSIVE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME, HUMAN; HUMANS; MALE; SEQUENCE ANALYSIS, DNA; WHOLE GENOME SEQUENCING;

EID: 85041390512     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.171151     Document Type: Article

References (70)

1. Shendure J, Balasubramanian S, Church GM, et al. DNA sequencing at 40: past, present and future. Nature 2017;550:345-53.
2. Lionel AC, Costain G, Monfared N, et al. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. Genet Med 2017 Aug. 3 [Epub ahead of print]. doi:10.1038/gim.2017.119.
3. Stavropoulos DJ, Merico D, Jobling R, et al. Whole genome sequencing expands diagnostic utility and improves clinical management in pediatric medicine. NPJ Genom Med 2016;1:pii:15012.
4. Jiang YH, Yuen RK, Jin X, et al. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am J Hum Genet 2013; 93:249-63.
5. Gilissen C, Hehir-Kwa JY, Thung DT, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature 2014;511:344-7.
6. Northcott PA, Buchhalter I, Morrissy AS, et al. The whole-genome landscape of medulloblastoma subtypes. Nature 2017;547:311-7.
7. Shlien A, Campbell BB, de Borja R, et al.; Biallelic Mismatch Repair Deficiency Consortium. Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers. Nat Genet 2015;47:257-62.
8. Linderman MD, Nielsen DE, Green RC. Personal genome sequencing in ostensibly healthy individuals and the PeopleSeq Consortium. J Pers Med 2016;6:E14.
9. Ali-Khan SE, Daar AS, Shuman C, et al. Whole genome scanning: resolving clinical diagnosis and management amidst complex data. Pediatr Res 2009;66: 357-63.
10. Lunshof JE, Chadwick R, Vorhaus DB, et al. From genetic privacy to open consent. Nat Rev Genet 2008;9:406-11.
11. Yuen RK, Thiruvahindrapuram B, Merico D, et al. Whole-genome sequencing of quartet families with autism spectrum disorder. Nat Med 2015;21:185-91.
12. Yuen RKC, Merico D, Bookman M, et al. Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nat Neurosci 2017;20:602-11.
13. MacDonald JR, Ziman R, Yuen RK, et al. The database of genomic variants: a curated collection of structural variation in the human genome. Nucleic Acids Res 2014;42:D986-92.
14. Cohn I, Paton TA, Marshall CR, et al. Genome sequencing as a platform for pharmacogenetic genotyping: a pediatric cohort study. NPJ Genom Med 2017;2:19.
15. Whirl-Carrillo M, McDonagh EM, Hebert JM, et al. Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther 2012;92:414-7.
16. Richards S, Aziz N, Bale S, et al.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-24.
17. Bowdin S, Ray PN, Cohn RD, et al. The genome clinic: a multidisciplinary approach to assessing the opportunities and challenges of integrating genomic analysis into clinical care. Hum Mutat 2014;35:513-9.
18. Bowdin S, Gilbert A, Bedoukian E, et al. Recommendations for the integration of genomics into clinical practice. Genet Med 2016;18:1075-84.
19. Trost B, Walker S, Wang Z, et al. A comprehensive workflow for read depthbased identification of copy-number variation from whole-genome sequence data. Am J Hum Genet 2018;102:142-55.
20. Struewing JP, Brody LC, Erdos MR, et al. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet 1995;57:1-7.
21. Miao M, Reichheld SE, Muiznieks LD, et al. Single nucleotide polymorphisms and domain/splice variants modulate assembly and elastomeric properties of human elastin. Implications for tissue specificity and durability of elastic tissue. Biopolymers 2017;107:e23007.
22. Savage DB, Soos MA, Powlson A, et al. Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene. Diabetologia 2004;47:753-6.
23. Piotrowski A, Xie J, Liu YF, et al. Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet 2014;46:182-7.
24. Leclerc D, Boutros M, Suh D, et al. SLC7A9 mutations in all three cystinuria subtypes. Kidney Int 2002;62:1550-9.
25. Frances F, Portoles O, Corella D, et al. SLC7A9 gene variation: impact of 13 frequent mutations in the etiology of cystinuria in a Spanish Mediterranean population [article in Spanish]. Med Clin (Barc) 2006;127:161-6.
26. Russell LM, Strike P, Browne CE, et al. X chromosome loss and ageing. Cytogenet Genome Res 2007;116:181-5.
27. Liu C, Wang Y, Wang QS, et al. The CHEK2 I157T variant and breast cancer susceptibility: a systematic review and meta-analysis. Asian Pac J Cancer Prev 2012;13:1355-60.
28. Han FF, Guo CL, Liu LH. The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysis. DNA Cell Biol 2013;32:329-35.
29. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
30. Reymer PW, Gagne E, Groenemeyer BE, et al. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat Genet 1995;10:28-34.
31. Reymer PW, Groenemeyer BE, Gagne E, et al. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum Mol Genet 1995;4:1543-9.
32. Hu Y, Liu W, Huang R, et al. A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases. J Lipid Res 2006;47:1908-14.
33. Tao H, Shinmura K, Hanaoka T, et al. A novel splice-site variant of the base excision repair gene MYH is associated with production of an aberrant mRNA transcript encoding a truncated MYH protein not localized in the nucleus. Carcinogenesis 2004;25:1859-66.
34. Win AK, Dowty JG, Cleary SP, et al. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology 2014;146:1208-11.e1-5.
35. Prasad A, Merico D, Thiruvahindrapuram B, et al. A discovery resource of rare copy number variations in individuals with autism spectrum disorder. G3 (Bethesda) 2012;2:1665-85.
36. Krumm N, O'Roak BJ, Karakoc E, et al. Transmission disequilibrium of small CNVs in simplex autism. Am J Hum Genet 2013;93:595-606.
37. Noor A, Lionel AC, Cohen-Woods S, et al. Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes. Am J Med Genet B Neuropsychiatr Genet 2014;165B:303-13.
38. Georgieva L, Rees E, Moran JL, et al. De novo CNVs in bipolar affective disorder and schizophrenia. Hum Mol Genet 2014;23:6677-83.
39. Mohler PJ, Schott JJ, Gramolini AO, et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003;421:634-9.
40. Mohler PJ, Splawski I, Napolitano C, et al. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc Natl Acad Sci U S A 2004;101:9137-42.
41. Le Scouarnec S, Bhasin N, Vieyres C, et al. Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease. Proc Natl Acad Sci U S A 2008;105:15617-22.
42. Kaurah P, MacMillan A, Boyd N, et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 2007;297:2360-72.
43. Figueiredo J, Soderberg O, Simoes-Correia J, et al. The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC. Eur J Hum Genet 2013;21:301-9.
44. Cox LE, Ferraiuolo L, Goodall EF, et al. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS One 2010;5:e9872.
45. Parkinson N, Ince PG, Smith MO, et al.; FReJA Consortium. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 2006;67:1074-7.
46. Keogh MJ, Kurzawa-Akanbi M, Griffin H, et al. Exome sequencing in dementia with Lewy bodies. Transl Psychiatry 2016;6:e728.
47. Gordon E, Panaghie G, Deng L, et al. A KCNE2 mutation in a patient with cardiac arrhythmia induced by auditory stimuli and serum electrolyte imbalance. Cardiovasc Res 2008;77:98-106.
48. Tester DJ, Will ML, Haglund CM, et al. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2005;2:507-17.
49. Blakely EL, Poulton J, Pike M, et al. Childhood neurological presentation of a novel mitochondrial tRNA(Val) gene mutation. J Neurol Sci 2004;225:99-103.
50. Green RC, Berg JS, Grody WW, et al.; American College of Medical Genetics and Genomics. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013;15:565-74.
51. Vassy JL, Christensen KD, Schonman EF, et al.; MedSeq Project. The impact of whole-genome sequencing on the primary care and outcomes of healthy adult patients: a pilot randomized trial. Ann Intern Med 2017 June 27 [Epub ahead of print]. doi:10.7326/M17-0188.
52. Chan EM, Young EJ, Ianzano L, et al. Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat Genet 2003;35:125-7.
53. Chardon JW, Smith AC, Woulfe J, et al. LIMS2 mutations are associated with a novel muscular dystrophy, severe cardiomyopathy and triangular tongues. Clin Genet 2015;88:558-64.
54. Morton NE, Crow JF, Muller HJ. An estimate of the mutational damage in man from data on consanguineous marriages. Proc Natl Acad Sci U S A 1956;42: 855-63.
55. Rego S, Dagan-Rosenfeld O, Zhou W, et al. High frequency actionable pathogenic exome mutations in an average-risk cohort. bioRxiv 2017 June 18 [Epub ahead of print]. doi:10.1101/151225.
56. Ball MP, Thakuria JV, Zaranek AW, et al. A public resource facilitating clinical use of genomes. Proc Natl Acad Sci U S A 2012;109:11920-7.
57. Gonzalez-Garay ML, McGuire AL, Pereira S, et al. Personalized genomic disease risk of volunteers. Proc Natl Acad Sci U S A 2013;110:16957-62.
58. Kalia SS, Adelman K, Bale SJ, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 2017;19:249-55.
59. Amendola LM, Dorschner MO, Robertson PD, et al. Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res 2015;25:305-15.
60. Amendola LM, Jarvik GP, Leo MC, et al. Performance of ACMG-AMP variantinterpretation guidelines among nine laboratories in the Clinical Sequencing Exploratory Research consortium. Am J Hum Genet 2016;98:1067-76.
61. Lek M, Karczewski KJ, Minikel EV, et al.; Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016; 536: 285-91.
62. Leung MKK, Delong A, Alipanahi B, et al. Machine learning in genomic medicine: a review of computational problems and data sets. Proc IEEE Inst Electr Electron Eng 2016;104:176-97.
63. Wenger AM, Guturu H, Bernstein JA, et al. Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers. Genet Med 2017;19:209-14.
64. Jobling MA, Tyler-Smith C. Human Y-chromosome variation in the genomesequencing era. Nat Rev Genet 2017;18:485-97.
65. Ledford H. AstraZeneca launches project to sequence 2 million genomes. Nature 2016;532:427.
66. Marx V. The DNA of a nation. Nature 2015;524:503-5.
67. Friend SH, Ideker T. Biomedical technology and the clinic of the future. Nat Biotechnol 2011;29:215.
68. Scriver CR. The human genome project will not replace the physician. CMAJ 2004;171:1461-4.
69. Field Y, Boyle EA, Telis N, et al. Detection of human adaptation during the past 2000 years. Science 2016;354:760-4.
70. McAlister FA, Laupacis A, Armstrong PW. Finding the right balance between precision medicine and personalized care. CMAJ 2017;189:E1065-8.